New Indications and Dosage Forms for 2009
See also: New Drug Approvals for 2009
January 9, 2009
February 5, 2009
February 26, 2009
February 27, 2009
March 3, 2009
March 5, 2009
March 20, 2009
March 23, 2009
March 24, 2009
May 6, 2009
May 11, 2009
May 13, 2009
- Azor Receives FDA Approval as First-Line Treatment for High Blood Pressure
- FDA Approves ACTOplus met XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
- UCB's Cimzia (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
May 14, 2009
May 18, 2009
May 26, 2009
May 28, 2009
June 1, 2009
- FDA Approves Reclast to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing
- FDA Approves Lamictal XR; An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
- FDA Approves Labeling Change for Vyvanse (lisdexamfetamine dimesylate) CII to Include Supplementary Clinical Data Supporting Efficacy at 13 Hours Postdose in Children Aged 6 to 12 with ADHD
June 3, 2009
June 10, 2009
June 11, 2009
July 7, 2009
July 20, 2009
July 21, 2009
July 23, 2009
July 29, 2009
August 3, 2009
August 6, 2009
August 25, 2009
August 31, 2009
September 2, 2009
September 4, 2009
October 2, 2009
October 7, 2009
October 16, 2009
- U.S. Food and Drug Administration Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
- FDA Approves Gardasil for Use in Boys and Young Men
- FDA Approves Elitek (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
October 19, 2009
- FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
- FDA Approves New Use for Micardis in Cardiovascular Risk Reduction
October 22, 2009
November 2, 2009
November 6, 2009
November 13, 2009
November 20, 2009
November 22, 2009
November 30, 2009
December 2, 2009
- U.S. Food And Drug Administration (FDA) Grants Traditional Approval for Intelence (etravirine)
- FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause